{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:47:08Z","timestamp":1791308828581,"version":"4.3.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.molimm.2008.06.031","type":"journal-article","created":{"date-parts":[[2008,8,4]],"date-time":"2008-08-04T14:11:09Z","timestamp":1217859069000},"page":"3878-3888","source":"Crossref","is-referenced-by-count":29,"title":["Molecular recognition of botulinum neurotoxin B heavy chain by human antibodies from cervical dystonia patients that develop immunoresistance to toxin treatment"],"prefix":"10.1016","volume":"45","author":[{"given":"M. Zouhair","family":"Atassi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behzod Z.","family":"Dolimbek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Jankovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance E.","family":"Steward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Roger","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2008.06.031_bib1","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0019-2791(75)90010-5","article-title":"Antigenic structure of myoglobin. The complete immunochemical anatomy of a protein and conclusions relating to antigenic structures of proteins","volume":"12","author":"Atassi","year":"1975","journal-title":"Immunochem."},{"key":"10.1016\/j.molimm.2008.06.031_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1432-1033.1984.tb08516.x","article-title":"Antigenic structures of proteins. Their determination has revealed important aspects of immune recognition and generated strategies for synthetic mimicking or protein binding sites","volume":"145","author":"Atassi","year":"1984","journal-title":"Europ. J. Biochem."},{"issue":"Suppl. 8","key":"10.1016\/j.molimm.2008.06.031_bib3","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1002\/mds.20020","article-title":"Basic immunological aspects of botulinum toxin therapy","volume":"19","author":"Atassi","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.molimm.2008.06.031_bib4","first-page":"219","article-title":"Structure, activity and immune (T and B Cell) recognition of botulinum neurotoxin","volume":"19","author":"Atassi","year":"1999","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.molimm.2008.06.031_bib5","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/0161-5890(78)90016-0","article-title":"A Proposal for the nomenclature of antigen sites in peptides and proteins","volume":"15","author":"Atassi","year":"1978","journal-title":"Immunochem."},{"key":"10.1016\/j.molimm.2008.06.031_bib6","first-page":"927","article-title":"Antibody and T-cell recognition of (-bungarotoxin and its synthetic loop peptides","volume":"13","author":"Atassi","year":"1995","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2008.06.031_bib7","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.molimm.2005.01.016","article-title":"Submolecular recognition profiles in two mouse strains of non-protective and protective antibodies against botulinum neurotoxin A","volume":"42","author":"Atassi","year":"2005","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2008.06.031_bib8","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1073\/pnas.88.9.3613","article-title":"Localization and synthesis of the hormone-binding regions of the human thyrotropin receptor","volume":"88","author":"Atassi","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molimm.2008.06.031_bib9","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1099\/mic.0.28862-0","article-title":"On the enhancement of anti-neurotoxin antibody production by subcomponents HA1 and HA3b of Clostridium botulinum type B 16S toxin-haemagglutinin","volume":"52","author":"Atassi","year":"2006","journal-title":"Microbiology"},{"key":"10.1016\/j.molimm.2008.06.031_bib10","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1016\/S0021-9258(18)61557-1","article-title":"Role of the heavy and light chains of botulinum neurotoxin in neuromuscular paralysis","volume":"262","author":"Bandyopadhyay","year":"1987","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molimm.2008.06.031_bib11","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/mda.2002.24423","article-title":"Botulinum toxin type A (BOTOX) for treatment of migraine","volume":"48","author":"Binder","year":"2002","journal-title":"Dis. Mon."},{"key":"10.1016\/j.molimm.2008.06.031_bib12","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0300-9084(00)01173-1","article-title":"Development of vaccines for prevention of botulism","volume":"82","author":"Byrne","year":"2000","journal-title":"Biochimie"},{"key":"10.1016\/j.molimm.2008.06.031_bib13","doi-asserted-by":"crossref","unstructured":"Campbell, K.D., Collins, M.D., East A.K., 1993. Gene probes for identification of the botulinal neurotoxin gene and specific identification of neurotoxin types B, E, and F. J. Clin. Microbiol. 31, 2255\u20132262. Also, B3: C. botulinum (strain non-proteolytic Eklund 2B) gene for neurotoxin type B. Accession # X70819. (Ref. same as B2); B4: C. botulinum (strain proteolytic B) gene for neurotoxin type B. Accession # X70817. (Ref. same as B2); B5: Clostridium botulinum neurotoxin type B (botB) gene, complete cds Accession # M81186.","DOI":"10.1128\/JCM.31.9.2255-2262.1993"},{"key":"10.1016\/j.molimm.2008.06.031_bib14","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/nature05411","article-title":"Structural basis of cell surface receptor recognition by botulinum neurotoxin B","volume":"444","author":"Chai","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.molimm.2008.06.031_bib15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1473-2165.2006.00250.x","article-title":"Botulinum toxin in dermatology\u2014beyond wrinkles and sweat","volume":"5","author":"Diamond","year":"2006","journal-title":"J. Cosmet. Dermatol."},{"key":"10.1016\/j.molimm.2008.06.031_bib16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-1-4684-4331-8_6","article-title":"Genetic control and intersite influences on the immune response to sperm whale myoglobin","volume":"150","author":"David","year":"1982","journal-title":"Advan. Exp. Med. Biol."},{"key":"10.1016\/j.molimm.2008.06.031_bib17","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1081\/IMM-120016244","article-title":"Cross-reaction of tetanus and Botulinum neurotoxins A and B and the boosting effect of Botulinum neurotoxins A and B on a primary anti-tetanus antibody response","volume":"31","author":"Dolimbek","year":"2002","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.molimm.2008.06.031_bib18","first-page":"490","article-title":"\u03b1-Bungarotoxin peptides afford a synthetic vaccine against toxin poisoning","volume":"13","author":"Dolimbek","year":"1994","journal-title":"J. Prot. Chem."},{"key":"10.1016\/j.molimm.2008.06.031_bib19","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0161-5890(96)00014-4","article-title":"Protection against (-bungarotoxin poisoning by immunization with synthetic toxin peptides","volume":"33","author":"Dolimbek","year":"1996","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2008.06.031_bib20","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.molimm.2006.03.011","article-title":"Mapping of the regions on the heavy chain of botulinum neurotoxin A (BoNT\/A) recognized by antibodies of cervical dystonia patients with immunoresistance to BoNT\/A","volume":"44","author":"Dolimbek","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2008.06.031_bib21","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.molimm.2007.08.007","article-title":"Immune recognition of botulinum neurotoxin B: antibody-binding regions on the heavy chain of the toxin","volume":"45","author":"Dolimbek","year":"2008","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2008.06.031_bib22","first-page":"119","article-title":"Mapping of the antibody and T cell recognition profiles of the HN domain (residues 449-859) of the heavy chain of botulinum neurotoxin A in two high-responder mouse strains","volume":"34","author":"Dolimbek","year":"2005","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.molimm.2008.06.031_bib23","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1123654","article-title":"SV2 Is the protein receptor for botulinum neurotoxin A","volume":"312","author":"Dong","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.molimm.2008.06.031_bib24","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.1021\/bi9723966","article-title":"Role of zinc in the structure and toxic activity of botulinum neurotoxin","volume":"37","author":"Fu","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.molimm.2008.06.031_bib25","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nbt1269","article-title":"Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum Neurotoxin","volume":"25","author":"Garcia-Rodriguez","year":"2007","journal-title":"Nature Biotechnol."},{"key":"10.1016\/j.molimm.2008.06.031_bib26","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1006\/exnr.1997.6580","article-title":"Botulinum A toxin therapy: neutralizing and nonneutralizing Abs\u2014therapeutic consequences","volume":"147","author":"G\u00f6schel","year":"1997","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.molimm.2008.06.031_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2036.2003.01598.x","article-title":"Review article: botulinum toxin in the therapy of gastrointestinal motility disorders","volume":"18","author":"Gui","year":"2003","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.molimm.2008.06.031_bib28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF01569055","article-title":"Nucleotide sequence of the gene coding for non-proteolytic Clostridium botulinum type B neurotoxin: comparison with other clostridial neurotoxins","volume":"28","author":"Hutson","year":"1994","journal-title":"Curr. Microbiol."},{"issue":"Suppl. 8","key":"10.1016\/j.molimm.2008.06.031_bib29","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1002\/mds.20024","article-title":"Treatment of cervical dystonia with botulinum toxin","volume":"19","author":"Jankovic","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.molimm.2008.06.031_bib30","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/S1474-4422(06)70574-9","article-title":"Treatment of dystonia","volume":"5","author":"Jankovic","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.molimm.2008.06.031_bib31","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1212\/01.wnl.0000249308.66959.43","article-title":"Clinico-immunologic aspects of botulinum toxin type B treatment of cervical dystonia","volume":"67","author":"Jankovic","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.molimm.2008.06.031_bib32","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/nature05387","article-title":"Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity","volume":"444","author":"Jin","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.molimm.2008.06.031_bib33","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1042\/bj1910261","article-title":"A novel and comprehensive synthetic approach for the elucidation of protein antigenic structures. Determination of the full antigenic profile of the alpha-chain of human haemoglobin","volume":"191","author":"Kazim","year":"1980","journal-title":"Biochem. J."},{"key":"10.1016\/j.molimm.2008.06.031_bib34","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1042\/bj2030201","article-title":"Structurally inherent antigenic sites. Localization of the antigenic sites of the alpha-chain of human haemoglobin in three host species by a comprehensive synthetic approach","volume":"203","author":"Kazim","year":"1982","journal-title":"Biochem. J."},{"key":"10.1016\/j.molimm.2008.06.031_bib35","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1042\/bj1670275","article-title":"Prediction and confirmation by synthesis of two antigenic sites in human haemoglobin by extrapolation from the known antigenic structure of sperm whale myoglobin","volume":"167","author":"Kazim","year":"1977","journal-title":"Biochem. J."},{"key":"10.1016\/j.molimm.2008.06.031_bib36","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1128\/IAI.57.9.2634-2639.1989","article-title":"Immunological characterization of papain-induced fragments of Clostridium botulinum type A neurotoxin and interaction of the fragments with brain synaptosomes","volume":"57","author":"Kozaki","year":"1989","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2008.06.031_bib37","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/2338","article-title":"Crystal structure of Botulinum neurotoxin type A and implications for toxicity","volume":"5","author":"Lacy","year":"1998","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.molimm.2008.06.031_bib38","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1023\/A:1020655701852","article-title":"In vitro translation of type A Clostridium botulinum neurotoxin heavy chain and analysis of its binding to rat synaptosomes","volume":"18","author":"Li","year":"1999","journal-title":"J. Prot. Chem."},{"key":"10.1016\/j.molimm.2008.06.031_bib39","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/j.febslet.2006.02.074","article-title":"The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves","volume":"580","author":"Mahrhold","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.molimm.2008.06.031_bib40","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jneumeth.2005.05.026","article-title":"Inhibition by human sera of botulinum neurotoxin-A binding to synaptosomes: a new assay for blocking and non-blocking antibodies","volume":"151","author":"Maruta","year":"2006","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.molimm.2008.06.031_bib41","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s10930-004-7881-3","article-title":"Mapping of the synaptosome-binding regions on the heavy chain of botulinum neurotoxin A by synthetic overlapping peptides encompassing the entire chain","volume":"23","author":"Maruta","year":"2004","journal-title":"Protein J."},{"key":"10.1016\/j.molimm.2008.06.031_bib42","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0304-3940(96)12557-X","article-title":"Binding of botulinum type B neurotoxin to Chinese hamster ovary cells transfected with rat synaptotagmin II cDNA","volume":"208","author":"Nishiki","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.molimm.2008.06.031_bib43","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0014-5793(95)01471-3","article-title":"The high-affinity binding of Clostridium botulinum type B neurotoxin to synaptotagmin II associated with gangliosides GT1b\/GD1a","volume":"378","author":"Nishiki","year":"1996","journal-title":"FEBS Lett."},{"key":"10.1016\/j.molimm.2008.06.031_bib44","doi-asserted-by":"crossref","first-page":"866","DOI":"10.4049\/jimmunol.121.3.866","article-title":"Genetic control of immune response to sperm whale myoglobin in mice. I. T lymphocyte proliferative response under H-2-linked Ir gene control","volume":"121","author":"Okuda","year":"1978","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2008.06.031_bib45","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1744-313X.1979.tb00699.x","article-title":"Genetic control of the immune response to hen's egg-white lysozyme in mice. I. Antibody and T-lymphocyte proliferative responses to the native protein","volume":"6","author":"Okuda","year":"1979","journal-title":"J. Immunogenet."},{"key":"10.1016\/j.molimm.2008.06.031_bib46","doi-asserted-by":"crossref","first-page":"182","DOI":"10.4049\/jimmunol.123.1.182","article-title":"Genetic control of immune response to sperm whale myoglobin in mice. II. T lymphocyte proliferative response to the synthetic antigenic sites","volume":"123","author":"Okuda","year":"1979","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2008.06.031_bib47","doi-asserted-by":"crossref","first-page":"23479","DOI":"10.1016\/S0021-9258(18)35863-0","article-title":"Botulinum neurotoxins are zinc proteins","volume":"267","author":"Schiavo","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molimm.2008.06.031_bib48","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1146\/annurev.pa.26.040186.002235","article-title":"Molecular pharmacology of botulinum toxin and tetanus toxin","volume":"26","author":"Simpson","year":"1986","journal-title":"Ann. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.molimm.2008.06.031_bib49","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/78005","article-title":"Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B","volume":"7","author":"Swaminathan","year":"2000","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.molimm.2008.06.031_bib50","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0968-0004(02)02177-1","article-title":"Botulinum and tetanus neurotoxins: structure, function and therapeutic utility","volume":"27","author":"Turton","year":"2002","journal-title":"Trends. Biochem. Sci."},{"key":"10.1016\/j.molimm.2008.06.031_bib51","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1042\/bj2340441","article-title":"Antigenic structure of human haemoglobin: localization of the antigenic sites of the \u03b2-chain in three host species by synthetic overlapping peptides representing the entire chain","volume":"234","author":"Yoshioka","year":"1986","journal-title":"Biochem. J."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589008002642?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589008002642?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T12:28:32Z","timestamp":1684499312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589008002642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":51,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0161589008002642"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2008.06.031","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}